A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 1993

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

DRUG

Didanosine

Trial Locations (5)

Univ of Pittsburgh, Pittsburgh

Whitman - Walker Clinic, Washington D.C.

Palo Alto Veterans Adm Med Ctr / Stanford Univ, Palo Alto

Univ of Washington, Seattle

Univ of Pittsburgh Med School, Pittsburgh